Site Search Results
Search returned 8 results.
-
THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients with Advanced Pancreatic Cancer
Open - Not yet RecruitingNCI Protocol ID NCI-20-C-0043Investigator Christine Campo Alewine, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number NCI Medical Oncology Referral Office (link sends e-mail) (240)760-6050 -
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Open - RecruitingNCI Protocol ID NCI-19-C-0039Investigator Jonathan M. Hernandez, M.D.
Share this trial: Referral ContactsContact Name Phone Number Maureen Connolly (link sends e-mail) 240-858-3734 -
Phase II Study of Nivolumab (anti-PD1), Tadalafil and Oral Vancomycin in Patients with Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer from Colorectal or Pancreatic Cancers
Open - RecruitingNCI Protocol ID NCI-19-C-0033Investigator Tim F. Greten, M.D. Share this trial: Referral ContactsContact Name Phone Number Donna Mabry Hrones (link sends e-mail) 301-451-4864 -
Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
Open - RecruitingNCI Protocol ID NCI-19-C-0135Investigator Naris Nilubol, M.D., F.A.C.S.Share this trial: Referral ContactsContact Name Phone Number Cara Kenney (link sends e-mail) 240-760-6233 -
A Phase I/II Study of the Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination with Stereotactic Body Radiation Therapy (SBRT) in Adults with Advanced Pancreas Cancer.
Open - Not yet RecruitingNCI Protocol ID NCI-20-C-0074Investigator Udo Rudloff, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number Katherine Lee-Wisdom (link sends e-mail) 240.858.3525 -
First-in-Human Phase I Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Metarrestin (ML-246) in Subjects with Metastatic Solid Tumors
Open - RecruitingNCI Protocol ID NCI-20-C-0023Investigator Udo Rudloff, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number Murielle Hogu (link sends e-mail) 240.858.3335 -
Tissue Procurement and Natural History Study of Patients with Malignant Mesothelioma and Other Mesothelin Expressing Cancers
Open - RecruitingNCI Protocol ID NCI-13-C-0202Investigator Raffit Hassan, M.D.Share this trial: Referral ContactsContact Name Phone Number Maria Gracia Agra (link sends e-mail) 240.858.3152 -
Phase 1 with Expansion Cohorts in a Study of NEO-201 In Adults with Chemo-resistant Solid Tumors
Open - RecruitingNCI Protocol ID NCI-18-C-0147Investigator Christina M. Annunziata, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number Irene Ekwede (link sends e-mail) 240-760-6126